SWM and ConvaTec Enter Long-Term Supply Agreement
24 Jan, 2022
Schweitzer-Mauduit International, Inc. (“SWM” or “SWM International”) and ConvaTec Ltd. (“ConvaTec”) are pleased to announce that they have entered into a multi-year supply agreement in conjunction with their amicable resolution of pending litigation between the companies. Terms of the settlement and the commercial agreement were not disclosed.
SWM International’s Scapa Healthcare Business Signs Exclusive Technology Licensing Agreement for Novel Wound Care Technology with Synedgen, Inc.
19 Oct, 2021
Scapa Healthcare and Synedgen have signed an exclusive worldwide licensing agreement for two novel innovative wound care treatments developed using Synedgen’s proprietary glycochemistry technology platform.
SWM International Completes Acquisition of Scapa Group Plc
15 Apr, 2021
Schweitzer-Mauduit International, Inc. (“SWM” or the “Company”) (NYSE: SWM), announced today that it has finalized its acquisition of Scapa Group Plc, a UK-based innovation, design, and manufacturing solutions provider for healthcare and industrial markets. The newly combined company’s annualized sales are approaching $1.5 billion.
Scapa Healthcare Boosts Manufacturing Capabilities at its Hydrocolloid Technology Center in Orangeburg, New York
6 Apr, 2021
Scapa Healthcare, the trusted strategic partner of choice for the world’s leading companies in advanced wound care, consumer wellness and medical device & fixation, today announced new enhancements at its Hydrocolloid Technology Center in Orangeburg, New York. The company continues to make significant investments to meet growing customer demands for premium medical-grade hydrocolloid adhesive technologies globally. This includes new automated and visual systems for ostomy and consumer products as well as enhancements to high-speed finished packaging, R&D capabilities, unique device identifier (UDI) systems for medical devices, and forecasting & supply chain management tools.
Scapa Healthcare Expands Topical Skin Care Capabilities at its Dallas, TX Technology Center
9 Mar, 2021
Scapa Healthcare, the trusted strategic partner of choice for the world’s leading companies in advanced wound care, consumer wellness and medical device & fixation, announced today the expansion and enhancement of its Technology Center in Dallas, TX. The company has undertaken significant investment in its topical skin care capabilities to meet increasing customer demands for medicated topical and cosmetic products.
Scapa Healthcare Enhances Manufacturing and Innovation Capabilities at its Knoxville, TN Center of Excellence
9 Feb, 2021
Scapa Healthcare announced the enhancement of its manufacturing and research & development capabilities at its Knoxville, TN center of excellence (COE). The company’s multimillion dollar investments at this facility have created four innovation and product development labs to provide a collaborative space for the development of new technologies and products; contract design and manufacturing operations for over-the-counter (OTC) drugs and pharmaceuticals; and the installation of high speed automated vision systems that enhance process controls to ensure quality and consistency.
Scapa Healthcare Expands Medical-Grade Adhesive Coating Capabilities Globally
13 Jan, 2021
Scapa Healthcare, the trusted strategic partner of choice for the world’s leading companies in advanced wound care, consumer wellness and medical device & fixation, today announced expanded medical-grade adhesive coating capabilities in its Windsor, CT and Gargrave, UK facilities. The newly added coating lines increase Scapa’s capacity to custom design and produce polyurethane and polyvinyl chloride foams coated with silicone gels, water-based and solvent-based acrylic adhesives.
Scapa Healthcare Announces Expansion of Sterilisation Irradiation Services in the UK
19 Nov, 2020
Scapa Healthcare provides a full range of sterilisation services including in-house gamma irradiation, microbiology, storage, product stability and global product distribution as well as technical expertise in electron beam and ethylene oxide sterilisation methods.
Scapa Healthcare Closes 2020 Fiscal Year with Resilient Operational Performance
23 Jul, 2020
Throughout the year, the Scapa Healthcare team remained has focused on executing its operational optimization plan and during the pandemic, the team demonstrated determination and adaptability while operating safely at all its global locations to ensure uninterrupted supply chain to its customers.
Scapa Healthcare Announces Proprietary Release System Design for Adhesive Patches and Dressings
5 Nov, 2019
Scapa Healthcare Set to Exhibit at MEDICA 2019
21 Oct, 2019
Scapa Healthcare will be exhibiting its industry leading, innovative and turn-key solutions in Hall 06, Stand 6H48 at MEDICA 2019.
Scapa Healthcare Opens New Medical Device Manufacturing Facility in Knoxville, TN
3 Jun, 2019
Scapa Healthcare inaugurates its new built-for-purpose medical device manufacturing facility in Knox County, Tennessee today.
Scapa Healthcare Introduces a Second-Generation Hydrocolloid Adhesive
21 Mar, 2019
The technology also offers high absorption properties which make it ideal for ostomy, wound care and consumer applications where the adhesive comes in contact with fluids. The technology is suitable for users with sensitive skin as the formulation is made of non-animal derived ingredients, colophony and is latex-free.
Scapa Healthcare Announces Hydrocolloid Offering for Acne Treatment
26 Feb, 2019
Scapa Healthcare, a global strategic outsource partner of skin friendly turn-key solutions, announces the availability of Scapa Soft-Pro® Hydrocolloid Acne Patches for the treatment of mild to moderate acne.
Scapa Healthcare Introduces Hydrocolloid Offering for Cold Sore Treatment
27 Nov, 2018
Discreet OTC Patches to Conceal & Prevent the Spread of the HSV-1 Virus.
Scapa Healthcare to Showcase Low Trauma Hydrocolloid Adhesive for Sensitive Skin Applications at MEDICA 2018
25 Oct, 2018
Extensive Toolkit Allows Customers to Bring Innovative Skin-contact Solutions to Market Rapidly
Scapa Healthcare Completes the Purchase of Systagenix Advanced Wound Dressing Facility in the UK
2 Oct, 2018
Acquisition Positions Scapa Healthcare as a Leading Manufacturer of Medical Devices
Scapa Healthcare Enters Agreement to Acquire Advanced Wound Dressing Facility in the UK
13 Sep, 2018
Transaction with Acelity to Expand Scapa Healthcare Advanced Wound Care Capabilities & Services
Scapa Healthcare Granted European Patent for New Hydrocolloid Adhesive Composition
23 Aug, 2018
Formulated with Natural Oils that Support Skin Hydration
Scapa Healthcare Closed Fiscal Year with Significant Enhancements of Capabilities and Technologies
25 Jun, 2018
Expanded North American Manufacturing Footprint through an Acquisition and New Manufacturing Site